Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0669486B2 - Method for producing collagen membrane having biological function - Google Patents
[go: Go Back, main page]

JPH0669486B2 - Method for producing collagen membrane having biological function - Google Patents

Method for producing collagen membrane having biological function

Info

Publication number
JPH0669486B2
JPH0669486B2 JP63309845A JP30984588A JPH0669486B2 JP H0669486 B2 JPH0669486 B2 JP H0669486B2 JP 63309845 A JP63309845 A JP 63309845A JP 30984588 A JP30984588 A JP 30984588A JP H0669486 B2 JPH0669486 B2 JP H0669486B2
Authority
JP
Japan
Prior art keywords
collagen
membrane
periodontal
biological function
collagen membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP63309845A
Other languages
Japanese (ja)
Other versions
JPH02156954A (en
Inventor
芳徳 久保木
煕 加藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sangi Co Ltd
Original Assignee
Sangi Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sangi Co Ltd filed Critical Sangi Co Ltd
Priority to JP63309845A priority Critical patent/JPH0669486B2/en
Publication of JPH02156954A publication Critical patent/JPH02156954A/en
Publication of JPH0669486B2 publication Critical patent/JPH0669486B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明はコラーゲン膜の製造法、詳しくは可溶性コラー
ゲンを線維状に再構成して、還元し安定化させた上で乾
燥し、膜を製造するコラーゲン膜の製造法、ならびに、
上記膜にコラーゲン以外の結合組織成分を配合して製造
する複合コラーゲン膜の製造法に関し、その膜は歯周疾
患などにより破壊された歯周組織(歯槽骨、セメント質
・歯根膜)をはじめとする各種の生体修復材料として使
用出来る。
DETAILED DESCRIPTION OF THE INVENTION (Industrial field of application) The present invention relates to a method for producing a collagen membrane, specifically, to reconstitute soluble collagen into a fibrous form, reduce and stabilize it, and then dry it to produce a membrane. A method for producing a collagen film, and
The present invention relates to a method for producing a composite collagen membrane, which is produced by mixing a connective tissue component other than collagen into the membrane, and the membrane includes periodontal tissue (alveolar bone, cementum, periodontal ligament) destroyed by periodontal disease and the like. It can be used as various bio-repair materials.

(従来の技術) 線維タンパク質コラーゲンは、ほ乳類、鳥類などの結合
組織、骨、歯、靱帯、腱、真皮及び筋膜などに広く分布
する生体タンパク質で、最近各種の医学、生物学的応用
が検討されている。例えば再構成したコラーゲンは、細
胞培養用の優れた支持体であるばかりでなく、人体の皮
下に注入することにより、陥凹した皮膚面に膨らみを与
えること(所謂しわのばし)などにも有効であり、各種
の可溶性コラーゲンが頭髪用、化粧用、家庭用、動物用
及び工業用製品に広く使用されている。又、コラーゲン
膜、例えばメタスキンは熱傷や皮膚欠損創に対する被覆
治療剤として医療に用いられている。
(Conventional technology) Fibrous protein collagen is a biological protein widely distributed in connective tissues of mammals, birds, etc., bones, teeth, ligaments, tendons, dermis, fascia, etc. Recently, various medical and biological applications have been investigated. Has been done. For example, reconstituted collagen is not only an excellent support for cell culture, but is also effective for giving swelling to the depressed skin surface (so-called wrinkle) by injecting subcutaneously into the human body. Thus, various soluble collagens are widely used in hair, cosmetic, household, animal, and industrial products. A collagen film, such as metaskin, is used in medicine as a therapeutic agent for coating burns and skin defect wounds.

しかしながら、現在使用されているコラーゲン膜は、や
や剛性があり、人体組織になじみ難く、柔らかさに欠け
ている。このため使用時生理食塩水で柔軟化する必要が
ある上、膜の種類によっては創に貼付時膜の表裏を区別
する必要があり、又創面と膜との間に浸出液が貯留し、
創面との密着が不良となる場合がある。これらの欠点を
有するため、コラーゲンを創に貼付すると、その自己吸
収性と保護効果により表皮形成を促進し、創面の治療が
促進されることが判明しているもにかかわらず、あまり
利用されていない。特に歯科領域での歯周疾患治療のよ
うな細かな処理を要する治療には使用されていない。そ
のためにこれらの欠点を改良するため種々検討が加えら
れている。
However, the collagen membranes currently used are rather rigid, hard to adapt to human tissues, and lacking in softness. For this reason, it is necessary to soften with physiological saline during use, and depending on the type of membrane, it is necessary to distinguish the front and back of the membrane when applied to the wound, and the exudate accumulates between the wound surface and the membrane,
The adhesion to the wound surface may be poor. Due to these drawbacks, it has been found that when collagen is applied to a wound, it promotes epidermal formation due to its self-absorbing property and protective effect, and promotes treatment of the wound surface, but it is not often used. Absent. Especially, it is not used for treatments that require fine treatment such as treatment of periodontal diseases in the dental field. Therefore, various studies have been added to improve these drawbacks.

(本発明が解決しようとする課題) 本発明は、従来のコラーゲン膜の有する欠点を除き、柔
軟で浸出組織液を吸収し創面との密着性が良く、使用時
その表皮形成促進効果を常に期待でき、細かな処理にも
使用出来るコラーゲン膜の製造法及びその膜を用いて歯
周疾患により破壊された歯槽骨・セメント質・歯根膜を
再生させる術式を確立するものである。
(Problems to be Solved by the Present Invention) The present invention, except for the drawbacks of conventional collagen membranes, is flexible and absorbs exudative tissue fluid and has good adhesion to the wound surface, and when used, its effect of promoting epidermal formation can always be expected. The present invention establishes a method for producing a collagen film that can be used for fine treatment and a method for regenerating alveolar bone, cementum, and periodontal ligament destroyed by periodontal disease using the film.

(課題を解決するための手段) コラーゲンの分子はケラチンなどのように高弾性を示さ
ないが、その構造上の特徴として中心軸の回りを三本ポ
リペプチド鎖がらせん状により合い、コラーゲン特有の
構造(コラーゲンヘリックス)を作っている。コラーゲ
ンの線維は、コラーゲン分子が規則的に配列し、その所
々をリジン及びハイドロキシリジンを介して、シッフ塩
基型を主とする架橋を形成して構造を安定化しているこ
とが知られている。可溶性コラーゲンは、コラーゲン分
子のモノマーとしての存在形態であり、コラーゲン線維
は分子がきわめて秩序だって配列したコラーゲン本来の
性能を発現する存在形態であることも知られている。従
って従来のコラーゲン膜は、可溶性コラーゲン溶液を常
法によりそのまま脱水乾燥して膜としているため、得ら
れた膜はコラーゲンがランダムに任意の方向に配位さ
れ、コラーゲン本来の機能を発揮し得ないことは明らか
である。そのため物理的性質としても剛性があり、柔軟
性に欠けるものとなっている。そこで膜にコラーゲン本
来の物理的性質を与え、また物理的性状としても弾性及
び柔軟性を与える方法を種種検討した。
(Means for solving the problem) Collagen molecules do not exhibit high elasticity like keratin, but as a structural feature, three polypeptide chains are helically aligned around the central axis, which is characteristic of collagen. Creating the structure (collagen helix). It is known that collagen fibers have a regular arrangement of collagen molecules and form a cross-link mainly having a Schiff base type through lysine and hydroxylysine to stabilize the structure. It is also known that soluble collagen is an existing form as a monomer of a collagen molecule, and collagen fiber is an existing form in which molecules have an extremely ordered arrangement and express the original performance of collagen. Therefore, in the conventional collagen membrane, the soluble collagen solution is dehydrated and dried as it is by a conventional method, so that the obtained membrane has collagen randomly coordinated in an arbitrary direction, and the original function of collagen cannot be exhibited. That is clear. Therefore, it has rigidity as a physical property and lacks flexibility. Therefore, various kinds of methods for giving the membrane the original physical properties of collagen and also giving elasticity and flexibility as physical properties were investigated.

その結果、可溶性コラーゲン溶液を平たい容器内で線維
状に再構成しゲル化させ、その後コラーゲンに存在する
アルドール縮合体、及びシッフ型の架橋結合を温和な還
元剤で還元して安定化することにより、コラーゲンが急
速に強度を増して強化ゲルとなること、さらに、コラー
ゲン以外の結合組織の成分、例えば骨形成タンパク質
(BMP)、を初めとする各種成長分化因子、並びに、ヒ
アルロン酸、コンドロイチン硫酸、粘着性タンパク質フ
ィブロネクチン、オステオネクチン等の細胞間マトリッ
クス成分をコラーゲン膜に配合することによりさらに生
物学的機能を賦与することができること、これらを常法
によりエタノールなどで徐々に脱水し乾燥すると得られ
る膜はフィルム状ではなく柔軟で柔らかい布状構造物に
なることを知った(以下このようして作った膜を架橋コ
ラーゲンシートと記す)。
As a result, the soluble collagen solution was reconstituted into a fibrous form in a flat container and gelled, and then the aldol condensate and the Schiff-type crosslinks present in collagen were reduced and stabilized by a mild reducing agent. , Collagen rapidly increases in strength to become a reinforced gel, and further, various growth differentiation factors including components of connective tissue other than collagen, such as bone morphogenetic protein (BMP), and hyaluronic acid, chondroitin sulfate, By adding intercellular matrix components such as the adhesive proteins fibronectin and osteonectin to the collagen membrane, it is possible to further impart a biological function. Membranes obtained by gradually dehydrating and drying these with ethanol etc. by a conventional method. Knew that it would be a soft and soft cloth-like structure instead of a film ( This was to make the film referred to as a cross-linked collagen sheet).

即ち本願は生物学的機能を備えた点で従来法とは基本的
に異なる架橋コラーゲンシートの製造法及びその使用を
目的としている。架橋コラーゲンシートの厚さは、ゲル
の厚さにより任意に調節でき、その強度及び柔軟性は使
用する還元剤及び結合組織成分の種類及びその処理条件
により調節可能である。牛、豚、その他動物由来の可溶
性コラーゲン及び分子末端部のテロペプチドを除いたコ
ラーゲン又はこのコラーゲンに結合組成々分、例えば骨
形成タンパク質(BMP)、ヒアルロン酸、コンドロイチ
ン硫酸、粘着性タンパク質フィブロネクチン、オステオ
ネクチン等、を添加した物質を中性化緩衝液に溶解して
pHを中性に調節する。そのコラーゲン濃度は特に限定さ
れないが高濃度溶液は取り扱い上問題を生じるので1%
以下の濃度、好ましくは0.2%程度の濃度に調製する。
又コラーゲンに結合組成々分を添加することは、えられ
る膜の強度、柔軟性を向上させるので好ましい。そのコ
ラーゲンに対する添加割合は、目的とする膜の性状によ
り任意に変化させることができ、特に限定されないが、
比較的少量の添加でよく、一般にコラーゲン重量に対
し、10重量%以下で充分である。この溶液をろ過滅菌の
上、水平に置かれた平板容器に注ぎゲル化させる。約37
℃で一晩放置してゲル化させる。得られたゲルを中性緩
衝液に保持させ、還元剤、例えば水素化ホウ素化合物の
ような弱い還元剤、好ましくは水素化ホウ素ナトリウム
で処理する。架橋コラーゲンシートの強度、柔軟性を増
すためには還元剤による生理的架橋の安定化の他、例え
ばヘキサメチレンジイソシアネートなどのような架橋剤
で人工的に架橋を導入することも出来る。架橋剤の種類
及びその処理条件を、目的とする架橋コラーゲンシート
の性質により選択するが、一般に還元剤として水素化ホ
ウ素ナトリウムを使用する場合、その量は使用されたコ
ラーゲンの約1/50〜1/10(重量)、好ましくは約1/30量
で、50℃以下の温度、好ましくは室温程度で1〜数時
間、ヘキサメチレンジイソシアネートを使用する場合は
コラーゲンの1/20〜1/10量で、室温で1〜数時間処理さ
れる。還元剤で処理されたゲルは、水洗により還元剤を
完全に除去した後、常法によりエタノールによる脱水を
繰り返し、最後に低温下に減圧乾燥して架橋コラーゲン
シートを得る。
That is, the present application aims at a method for producing a crosslinked collagen sheet which is basically different from the conventional method in that it has a biological function and its use. The thickness of the cross-linked collagen sheet can be arbitrarily adjusted by the thickness of the gel, and its strength and flexibility can be adjusted by the type of reducing agent and connective tissue component used and its processing conditions. Soluble collagen derived from cattle, pigs, and other animals and collagen excluding the telopeptide at the molecular end or binding components to this collagen such as bone morphogenetic protein (BMP), hyaluronic acid, chondroitin sulfate, adhesive protein fibronectin, osteo Dissolve substances such as Nectin in neutralization buffer
Adjust pH to neutral. The collagen concentration is not particularly limited, but a high concentration solution causes a problem in handling, so 1%
The concentration is adjusted to the following, preferably about 0.2%.
In addition, it is preferable to add various binding compositions to collagen because it improves the strength and flexibility of the obtained membrane. The ratio of addition to the collagen can be arbitrarily changed according to the properties of the target film, and is not particularly limited,
A relatively small amount may be added, and generally 10% by weight or less based on the weight of collagen is sufficient. The solution is sterilized by filtration and then poured into a flat plate container placed horizontally to cause gelation. About 37
Allow to gel overnight at ℃. The gel obtained is kept in a neutral buffer and treated with a reducing agent, for example a weak reducing agent such as a borohydride compound, preferably sodium borohydride. In order to increase the strength and flexibility of the crosslinked collagen sheet, it is possible to stabilize physiological crosslinking with a reducing agent and artificially introduce crosslinking with a crosslinking agent such as hexamethylene diisocyanate. The type of the cross-linking agent and its treatment conditions are selected according to the properties of the cross-linked collagen sheet of interest, but when sodium borohydride is generally used as the reducing agent, the amount thereof is about 1/50 to 1 of the collagen used. / 10 (weight), preferably about 1/30 amount, at a temperature of 50 ° C. or lower, preferably about room temperature for 1 to several hours, when hexamethylene diisocyanate is used, 1/20 to 1/10 amount of collagen It is treated at room temperature for 1 to several hours. The gel treated with a reducing agent is washed with water to completely remove the reducing agent, and then dehydrated with ethanol is repeated by a conventional method, and finally dried under reduced pressure at a low temperature to obtain a crosslinked collagen sheet.

このようにして得られた架橋コラーゲンシートは組織に
貼付されるとき、最終的に組織に吸収され、柔らかい布
状で強度が強いのでいかなる組織にも貼付でき、密着す
る。又、コラーゲンは免疫原性が低く、分子末端のテロ
ペプチドを除いた場合はさらに低くなり、細胞に対し異
物としての作用は少なく親和性に優れている。従って、
この架橋コラーゲンシートを歯周組織の再生材料として
歯周疾患における歯肉弁剥離手術時、歯表面に使用する
と、手術後の歯周組織の再生が著しく良好で歯周疾患の
治療を促進させる。即ち結合組織成分コラーゲンシート
は従来、歯周治療に一部使用されていた生体内非吸収性
のミリポア・フィルターの欠点を補い、これに取って代
わる新材料としての使用を可能にしている。第1図に歯
肉上皮が正常に付着していない歯周疾患の図を、第2図
に歯肉弁剥離手術時、架橋コラーゲンシートを歯に貼付
させた図を、第3図に歯肉・歯槽骨・セメント質・歯根
膜が再生し、歯肉が正しく歯に付着した図を示したが、
架橋コラーゲンシートを歯表面に密着させたため、上皮
は歯根方向に向かって不必要な増殖を示さず、上皮本来
の位置にとどまり、その下には歯槽骨・セメント質が再
生し、歯根膜が正しく歯根の周囲を包んでいる。そのた
め第1図にみられるような歯肉上皮の歯根方向への侵入
が生ぜず、歯周疾患の治療にきわめて大きな効果をもた
らす。
When the crosslinked collagen sheet thus obtained is attached to a tissue, it is finally absorbed by the tissue, and since it is a soft cloth and has a high strength, it can be attached to any tissue and adheres thereto. Further, collagen has a low immunogenicity, and becomes even lower when the telopeptide at the molecular end is removed, and has a low affinity as a foreign substance to cells and an excellent affinity. Therefore,
When this crosslinked collagen sheet is used as a regenerating material for periodontal tissue on the tooth surface during periodontal disease gingival flap exfoliation surgery, regeneration of periodontal tissue after surgery is remarkably good and treatment of periodontal disease is promoted. That is, the connective tissue component collagen sheet compensates for the shortcomings of the non-absorbable Millipore filter which has been conventionally used for partly in periodontal treatment, and enables use as a new material to replace it. Fig. 1 is a diagram of periodontal disease in which gingival epithelium is not normally attached, Fig. 2 is a diagram in which a crosslinked collagen sheet is attached to teeth during gingival flap detachment surgery, and Fig. 3 is gingival and alveolar bone.・ The figure shows that the cementum and periodontal ligament were regenerated and the gums were correctly attached to the teeth.
Since the cross-linked collagen sheet was adhered to the tooth surface, the epithelium did not show unnecessary proliferation toward the root of the tooth, remained in the original position of the epithelium, under which alveolar bone and cementum were regenerated, and the periodontal ligament was correctly formed. Wraps around the roots. Therefore, the invasion of the gingival epithelium in the direction of the tooth root as shown in FIG. 1 does not occur, which is extremely effective in treating periodontal diseases.

(作用) 架橋コラーゲンシートは可溶性コラーゲンを線維として
再構成した後、還元剤処理して、さらには必要に応じて
人工的に結合組織成分を導入して作製してある。このた
め従来のようにコラーゲン分子を無秩序な状態のまま乾
燥したものとは全く異なり、本願によるコラーゲン膜は
生物学的機能を保持し、剛性がなく、柔軟で強い布状を
なすため細かな細工に適している。以下、実施例をあげ
て本発明を説明する。
(Function) The crosslinked collagen sheet is produced by reconstituting soluble collagen into fibers, treating it with a reducing agent, and further artificially introducing connective tissue components as necessary. For this reason, unlike the conventional one in which collagen molecules are dried in a disordered state, the collagen membrane according to the present application retains its biological function, is rigid, and has a flexible and strong cloth-like shape. Suitable for Hereinafter, the present invention will be described with reference to examples.

例1. 牛の皮膚組織から得られた0.3%酸可溶性コラーゲン0.1
M酢酸溶液(pH3)7容をろ過滅菌した後、0.5M HEPES緩
衝液を1容、1M NaOHを2容混合し、均質とし、pHが中
性であることを確認した後、20×10cmの底面積を有する
平板に均一に注ぎこみ、平板を37±1℃の恒温槽に一晩
放置してゲルを得た。このゲルをpH7のリン酸緩衝液400
mlに保持し、140mgのNaBH4を添加し、1時間室温に保持
した。水層を除去した後、水洗して還元剤を除いた後エ
チルアルコールによる脱水を常法により行い、充分にエ
チルアルコールで脱水後室温下に減圧乾燥して厚さ約20
μのコラーゲン膜を得た。市販のもの(メタスキン)に
比し剛性がなく、柔軟性を有していた。
Example 1. 0.3% acid soluble collagen 0.1 from bovine skin tissue
After sterilizing 7 volumes of M acetic acid solution (pH 3) by filtration, 1 volume of 0.5 M HEPES buffer and 2 volumes of 1 M NaOH were mixed to homogenize, and after confirming that the pH was neutral, 20 × 10 cm It was poured evenly on a flat plate having a bottom area, and the flat plate was left overnight in a constant temperature bath at 37 ± 1 ° C. to obtain a gel. Apply this gel to pH 7 phosphate buffer 400
It was kept at ml, 140 mg of NaBH 4 was added, and it was kept at room temperature for 1 hour. After removing the aqueous layer, the product is washed with water to remove the reducing agent and dehydrated with ethyl alcohol by a conventional method. After dehydration with ethyl alcohol, the product is dried under reduced pressure at room temperature to a thickness of about 20.
A μ collagen film was obtained. It was less rigid and more flexible than a commercially available product (Metaskin).

例2. 例1により得られたコラーゲン膜を歯周疾患の歯肉弁剥
離手術時の歯表面に第2図で示したように貼付密着させ
た。膜を使用すると、歯肉上皮の根尖側移動が阻止され
歯根膜や骨から若い細胞が分化増殖して、歯槽骨・セメ
ント質・歯根膜を再生させる。一方、膜を使用しない場
合は、図1のように上皮が下方に成長してしまい、歯槽
骨・セメント質・歯根膜の再生はごくわずかしか生じな
かった。
Example 2. The collagen film obtained in Example 1 was attached and adhered to the tooth surface at the time of periodontal disease gingival flap exfoliation surgery as shown in FIG. When a membrane is used, the apical movement of the gingival epithelium is blocked and young cells are differentiated and grown from the periodontal ligament and bone to regenerate alveolar bone, cementum and periodontal ligament. On the other hand, when the membrane was not used, the epithelium grew downward as shown in FIG. 1, and the regeneration of alveolar bone, cementum and periodontal ligament occurred only slightly.

(効果) 本発明により得られる架橋コラーゲンシートは強く柔軟
で布状であるのでいかなる微細な操作にも対応でき、人
工皮膚として優れている。
(Effect) Since the crosslinked collagen sheet obtained by the present invention is strong, flexible and cloth-like, it can be applied to any fine operation and is excellent as artificial skin.

加えて本発明によりえられる架橋コラーゲンシートは人
工歯根膜ならびに人工皮膚の他に次のような医学的応用
に十分有効性を発揮する。過去においてヒト硬膜から、
そのままコラーゲン膜を剥離して臨床用として市販され
た膜があり、広範囲な応用がなされてきた。しかしなが
ら、この材料はヒトの死後材料から得たものであり、現
在ではエイズの問題がからみ、殆ど使用できない。これ
に代わる人工膜として本願の内容のものが使用できる。
更に、応用可能例を以下に例示する。
In addition to the artificial periodontal ligament and the artificial skin, the crosslinked collagen sheet obtained by the present invention is sufficiently effective for the following medical applications. From human dura in the past,
There is a film commercially available for clinical use by peeling the collagen film as it is, and it has been widely applied. However, this material was obtained from post-mortem material in humans and is now almost unusable due to AIDS problems. As an artificial membrane that replaces this, the one described in the present application can be used.
Further, applicable examples will be illustrated below.

歯周疾患により破壊された歯周組織の修復 歯肉移植術における歯肉供給部位の保護など 神経外科における硬膜の置換 髄液瘻の閉鎖 眼窩床の置換(ハンモック形成) 上顎洞の壁形成 口腔前庭修復 心膜の置換 横隔膜の外腹欠損部、先天性裂孔の閉鎖 腹壁ヘルニアの筋膜強化、又は置換 腱近位の置換と強化、癒着防止用被包 膀胱の形成的拡大 アキレス腱断裂手術の際の被包強化 その他Repair of periodontal tissue destroyed by periodontal disease Protection of gingival supply site during gingival transplantation Replacement of dura in neurosurgery Closure of cerebrospinal fistula Replacement of orbital bed (hammock formation) Wall formation of maxillary sinus Mouth vestibular repair Replacement of the pericardium External abdominal defect of the diaphragm, closure of congenital hiatus Fascia strengthening or replacement of abdominal wall hernia Replacement and strengthening of the tendon proximal, encapsulation to prevent adhesions Plastic expansion of the bladder Coverage during Achilles tendon tear surgery Package strengthening Other

【図面の簡単な説明】[Brief description of drawings]

第1図は歯周疾患に罹患し、深い歯周ポケットが形成さ
れ、歯槽骨は吸収し、セメント質と歯根膜も大幅に破壊
され、歯肉が正しく歯面に付着していない歯周疾患の歯
の断面図である。 第2図は歯周疾患り患歯の歯肉弁剥離手術時に、本願架
橋コラーゲンシートを歯から骨の表面にかけ貼付密着さ
せた歯の断面図である。 第3図は完治した歯の断面図である。 図中 1.歯槽骨 2.セメント質 3.歯根膜 4.歯肉 5.歯周ポケット 6.架橋コラーゲンシート 7.歯槽骨の再生 8.セメント質の再生 9.歯根膜の再生
Fig. 1 shows that periodontal disease in which deep periodontal pockets are formed, alveolar bone is absorbed, cementum and periodontal ligament are greatly destroyed, and gingiva is not properly attached to the tooth surface. It is sectional drawing of a tooth. FIG. 2 is a cross-sectional view of a tooth in which the cross-linked collagen sheet of the present application is stuck and adhered from the tooth to the surface of the bone at the time of gingival flap peeling surgery for a tooth with periodontal disease. FIG. 3 is a sectional view of a completely cured tooth. In the figure 1. Alveolar bone 2. Cementum 3. Periodontal ligament 4. Gingiva 5. Periodontal pocket 6. Crosslinked collagen sheet 7. Regeneration of alveolar bone 8. Regeneration of cementum 9. Regeneration of periodontal ligament

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】可溶性コラーゲンを線維状に再構成し、水
素化ホウ素化合物で処理することを特徴とするコラーゲ
ン膜の製造法。
1. A method for producing a collagen membrane, which comprises reconstituting soluble collagen into a fibrous form and treating it with a borohydride compound.
【請求項2】請求項1のコラーゲン膜の製造時に、骨形
成タンパク質(BMP)、ヒアルロン酸、コンドロイチン
硫酸、粘着性タンパク質フィブロネクチン及びオステオ
ネクチンより選ばれた少なくとも1つを混合して製造し
た複合コラーゲン膜の製造法。
2. A composite collagen produced by mixing at least one selected from bone morphogenetic protein (BMP), hyaluronic acid, chondroitin sulfate, adhesive protein fibronectin and osteonectin during the production of the collagen membrane according to claim 1. Membrane manufacturing method.
JP63309845A 1988-12-09 1988-12-09 Method for producing collagen membrane having biological function Expired - Fee Related JPH0669486B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63309845A JPH0669486B2 (en) 1988-12-09 1988-12-09 Method for producing collagen membrane having biological function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63309845A JPH0669486B2 (en) 1988-12-09 1988-12-09 Method for producing collagen membrane having biological function

Publications (2)

Publication Number Publication Date
JPH02156954A JPH02156954A (en) 1990-06-15
JPH0669486B2 true JPH0669486B2 (en) 1994-09-07

Family

ID=17997975

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63309845A Expired - Fee Related JPH0669486B2 (en) 1988-12-09 1988-12-09 Method for producing collagen membrane having biological function

Country Status (1)

Country Link
JP (1) JPH0669486B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7683106B2 (en) 2003-03-07 2010-03-23 Nippon Synthetic Chemical Industry Co., Ltd. Primer for dental materials and pulp capping agent for dentin regeneration
JP4592302B2 (en) * 2003-03-07 2010-12-01 日本合成化学工業株式会社 Dentin regenerated pulp capping agent
JP4636586B2 (en) * 2003-03-26 2011-02-23 日本合成化学工業株式会社 Primer for dental material
DE102020108991A1 (en) * 2020-04-01 2021-10-07 Andreas Haas PROCESS FOR REPROCESSING MOLDED COLLAGEN BODIES AND MOLDED COLLAGEN BODIES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3042860A1 (en) * 1980-11-13 1982-06-09 Heyl & Co Chemisch-Pharmazeutische Fabrik, 1000 Berlin COLLAGEN PREPARATIONS, METHODS FOR THEIR PRODUCTION AND THEIR USE IN HUMAN AND VETERINE MEDICINE
JPS62266064A (en) * 1986-05-14 1987-11-18 株式会社 高研 Production of collagen membrane

Also Published As

Publication number Publication date
JPH02156954A (en) 1990-06-15

Similar Documents

Publication Publication Date Title
Meena et al. Biomedical and industrial applications of collagen
Patino et al. Collagen as an implantable material in medicine and dentistry
KR100395724B1 (en) Hard Tissue Stimulating Agent
JP4137382B2 (en) Collagen tissue composition
RU2532370C2 (en) Tissue regeneration method and membrane
JP3577083B2 (en) film
US4233360A (en) Non-antigenic collagen and articles of manufacture
EP0429438B1 (en) Bone repair using collagen
US5567806A (en) Collagen crosslinked with a crosslinking agent for the manufacture of a suturable, biocompatible slowresorbing membrane, and such a membrane
US4488911A (en) Non-antigenic collagen and articles of manufacture
US4140537A (en) Aqueous collagen composition
JP4214051B2 (en) Elastin crosslinked body and method for producing the same
Abedi et al. Collagen-based medical devices for regenerative medicine and tissue engineering
JPS6237020B2 (en)
Gorham Collagen
CN110585484A (en) Composite bone powder for bone tissue and preparation method and application thereof
JP2004081739A (en) Hydroxyapatite-polymer composite hemostatic composition
JPH0669486B2 (en) Method for producing collagen membrane having biological function
JPWO2003094985A1 (en) Artificial extracellular matrix and method for producing the same
RU2197974C1 (en) Biocompositional material used in substituting osseous defects
JPH07236688A (en) Composite material of bioabsorptive plastic and collagen
CN117180489A (en) Microfiber collagen hemostatic material and preparation method and application thereof
CN115803356B (en) Biomaterials including at least one elastomer matrix and non-sulfated polysaccharides and their uses
JPS6162459A (en) Repairing of bone using collagen
Bakos MEMBRANES AND BONE SUBSTITUTES IN RECONSTRUCTIVE SURGERY

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees